Clinical Trial Update: Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure

View source ↗

Summary

A study at UConn Health is examining circulating biomarkers that accompany the progression from compensated hypertrophy to heart failure, and the trial is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Snippet

Sponsor: UConn Health | Conditions: Acute Decompensated Heart Failure, Heart Failure | Status: RECRUITING